Skip to content

Exelixis EXEL Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
Pfizer logo
PfizerPFE
$42.82B-6.6%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$616.6M+66.3%
Incyte logo
IncyteINCY
$5.48B+56.4%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.94B+21.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.24B+78.6%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's total current assets?
Exelixis (EXEL) reported total current assets of $1.21B in Q1 2026.
How has Exelixis's total current assets changed year-over-year?
Exelixis's total current assets decreased by 13.5% year-over-year, from $1.4B to $1.21B.
What is the long-term trend for Exelixis's total current assets?
Over 5 years (2020 to 2025), Exelixis's total current assets has grown at a -0.0% compound annual growth rate (CAGR), from $1.45B to $1.44B.
What does total current assets mean?
The total value of all assets the company expects to turn into cash within one year.
How do you interpret total current assets?
Higher levels indicate stronger short-term liquidity and operational flexibility to fund research and commercialization efforts.
How does total current assets compare across companies?
Standard metric for assessing short-term solvency; peers are compared based on their current ratio and liquidity position.